Annual Information Service
Rx Price Index Database
|Published by||Black Swan Analysis||Product code||780390|
|Published||annual subscription||Content info|
Please contact us using the inquiry form for pricing information.
|Rx Price Index Database|
|Published: annual subscription||Content info:||
The Rx Price Index™ is an online database that pulls together pricing information for all licensed available pharmaceutical products across the European markets and other select countries.
The Rx Price Index™ platform is designed to support business decisions and business cases around value-based pricing by providing competitor price points, European launch orders and loss of exclusivity (LOE) driven price events. Furthermore, our pricing data can be used within commercial forecasts since it has been validated, can be referenced, and represents a harmonised dataset and price point that is equal and comparable regardless of the market. All margins and mark-ups are transparent and checked against individual market assumptions and insight.
Extensive coverage of 32 global markets with additional countries added every month based on demand.
An easy to use interface makes it simple to conduct a rapid analysis of the European therapeutic landscape to understand the competitive environment and determine price points.
The platform displays ex-factory, wholesaler, pharmacy and retail prices calculated from country-specific margins and mark-ups. This includes consultation with local experts to validate the assumptions used in determining these price points.
The database can export data queries to Excel, to allow easy integration of data into your analysis and forecasts.
The Rx Price Indexfacilitates seamless navigation across the database to find the prices you need in a matter of seconds.
To enable regular monitoring of trends and events, monthly updates of the current pricing developments and new product launches are included along with longitudinal data from June 2015.
The Rx Price Index™ covers 32 global markets with future expansions scheduled
This is a live database and is updated regularly.
Download required information to Excel instantly and generate trends, spot launch order patterns and analyse LOE events based on price that can be used for business cases, commercial forecast inputs, market access models or early/late phase asset valuations.
The Rx Price Index™ provides an intuitive user interface to present; longitudinal pricing data from June 2015 to date, rolling monthly updates, four price types (ex-factory, wholesaler, pharmacy and retail) with margin and mark-up assumptions and an expanding country coverage of 32 global markets currently in the database, all with a single log-in.
The platform combines both private and public sources of information to provide accurate and complete country coverage. Multiple sources per country are used to verify both accuracy and product coverage, providing an unparalleled comprehensive dataset for prescription medicines.
Directly compare drug prices across markets. All our information is translated and harmonised to an internal standard using a series of data libraries and algorithms to maintain high-quality data across the platform.
Rx Price Index also displays the reimbursed price for prescription products across 14 European markets.
Country specific margins, fees and taxes are applied to the published price to generate pricing across the whole product value chain. Countries publish pharmaceutical product list prices; however, this may be different to the ex-factory price. By applying country specific margins and mark-ups and with a thorough understanding of the country's healthcare system the different price types are calculated.
Analytical tools are added to Rx Price Index™ to allow easy and effortless data manipulation and analysis directly on the platform. A variety of tools are being developed allowing for both product analysis, (price tracking, biosimilar launch tracking) and market analysis tools that will provide an initial assessment of the European market such as competitor analysis.
|Area||Question||Rx Price Index™ Solution|
|Competitive Landscape||Which competitor drugs are available in which European markets and what price are they set at?||Providing a comprehensive snapshot of the market giving a reliable picture of the competitive terrain. You will be able to access product information down to the product pack size and strength.|
|Launch Planning||How does the database enable me to determine the optimal launch sequence for new products?||Determine the optimal launch sequence for new products based on EU reference market price points. Analyse your competitor's launch pattern and price setting and/or the impact that an LOE event will have on price erosion|
|Pricing||What price can I set for my drug?||Lay the foundation for a transparent pricing strategy based on established price points in the market. All pricing information is sourced, and margins and mark-ups are documented therefore allowing you to build a robust and accurate pricing strategy.|
|Custom Access||Can I access the data partially or request custom reports?||Should you not find the data that you are looking for or would require analysis of the data we can prepare ad-hoc client-based custom reports tailored to your needs. Drop us an email for more information|